Track the PAR stock price and the full management transaction log of the company, a publicly traded company based in Australia. Shares trade on the AU market, under the supervision of ASX. Operating in the Health Care sector, PAR has published 2 public disclosures. Market capitalisation: €107.9m. The latest transaction was filed on 1 July 2026 (Other). Every trade is openly available.
Analysts rate PAR Strong Buy (bullish), based on 2 analysts. Average price target: A$1.08.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
PAR is a company operating in the healthcare and pharmaceutical sector, listed on the XASX. It focuses on the development and commercialization of innovative solutions for patient well-being.